Endocrine Therapy for HR+ Metastatic Breast Cancer

home / investigator-perspectives / tripathy-endocrine-therapy-breast-cancer

Breast Cancer

Overview of Recent FDA Approvals for Metastatic HR+ Breast Cancer

EP. 1: Overview of Recent FDA Approvals for Metastatic HR+ Breast Cancer

July 10th 2018

Watch

Treatments for HR+, HER2-Negative Metastatic Breast Cancer

EP. 2: Treatments for HR+, HER2-Negative Metastatic Breast Cancer

July 10th 2018

Watch

Discussing the Latest Results From the MONALEESA-3 Study

EP. 3: Discussing the Latest Results From the MONALEESA-3 Study

July 10th 2018

Watch

Discussing the Latest Data From the MONALEESA-7 Study

EP. 4: Discussing the Latest Data From the MONALEESA-7 Study

July 10th 2018

Watch

How Do You Decide on an Appropriate Endocrine Therapy?

EP. 5: How Do You Decide on an Appropriate Endocrine Therapy?

July 10th 2018

Watch

Is There Still a Role for Fulvestrant Hormone Monotherapy?

EP. 6: Is There Still a Role for Fulvestrant Hormone Monotherapy?

July 10th 2018

Watch